Johnson & Johnson (NYSE:JNJ) persuaded a judge to throw out a woman’s lawsuit arguing a vaginal-mesh implant was defectively designed, ending the first trial of claims the device caused patients’ injuries. Johnson & Johnson (NYSE:JNJ) stock opened at $92.15 in last session, and closed at $92.15, while the day range of stock is $91.57 – $92.75. The stock showed a negative weekly performance of -1.43%.
Pfizer Inc. (NYSE:PFE) is struggling to find new sources of growth given that its blockbuster drugs are losing patent protection. The company has had Viagra which is used for erectile dysfunction and Celebrex which is used for arthritis as two of its best selling drugs. Pfizer Inc. (NYSE:PFE) stock opened at $31.92, in last session and closed at $31.48, by losing -1.25%. The 52 week range of the stock is $26.82 – $32.50. Company’s market capitalization is $204.02 billion.
Merck & Co (NYSE:MRK)‘s stock had its “buy” rating reiterated by research analysts at TheStreet in a report released on Wednesday, Stock Ratings Network.com reports. Merck & Co., Inc. (NYSE:MRK) stock decreased -1.17% and finished the last session at $55.04. The EPS of the stock remained 1.48. Company’s market capitalization is $161.08 billion.
CURx Pharmaceuticals announced it has entered into a global license agreement with Gilead Sciences Inc (NASDAQ:GILD). Gilead Sciences, Inc. (NASDAQ:GILD) stock opened the session at $83.65, and closed the session at $82.70. The 52 week range of the stock remained $41.18 – $84.40 and the day range was $82.30 – $83.80.
Leave a Reply